Patents by Inventor Caroline Eriksson

Caroline Eriksson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine
    Publication number: 20100249196
    Abstract: Phosphoric acid, edisylic acid (1,2-ethanedisulfonic acid), citric acid, orotic acid (uracil-6-carboxylic acid), R-mandelic acid, sulfuric acid, 1,5-naphthalenedisulfonic acid, D-aspartic acid, and lysine monohydrochloride salts of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, and methods for their preparation, pharmaceutical compositions comprising said salts, and use, are disclosed. The salts can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders.
    Type: Application
    Filed: May 8, 2007
    Publication date: September 30, 2010
    Applicants: ASTRAZENECA AB, TARGACEPT, INC.
    Inventors: Martin Hans Bohlin, Gary M. Dull, Caroline Eriksson, Craig H. Miller, Julio A. Munoz, Tesfai Sebhatu
  • Compounds for the treatment of neurological, psychiatric or pain disorders
    Patent number: 7476684
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: January 13, 2009
    Assignee: AstraZeneca AB
    Inventors: Alexander Minidis, David Wensbo, Methvin Isaac, Abdelmalik Slassi, Jalaj Arora, Tao Xin, Louise Edwards, Caroline Eriksson, Veronica Profir, Per-Olov Bergstrom
  • NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
    Publication number: 20070270468
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: July 27, 2007
    Publication date: November 22, 2007
    Inventors: Alexander MINIDIS, David WENSBO, Methvin ISAAC, Abdelmalik SLASSI, Jalaj ARORA, Tao XIN, Louise EDWARDS, Caroline ERIKSSON, Veronica PROFIR, Per-Olov BERGSTROM
  • NEW COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL, PSYCHIATRIC OR PAIN DISORDERS
    Publication number: 20070270469
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: July 27, 2007
    Publication date: November 22, 2007
    Inventors: Alexander MINIDIS, David WENSBO, Methvin ISAAC, Abdelmalik SLASSI, Jalaj ARORA, Tao XIN, Louise Edwards, Caroline ERIKSSON, Veronica PROFIR, Per-Olov BERGSTROM
  • New compounds for the treatment of neurological, psychiatric or pain disorders
    Publication number: 20070129408
    Abstract: The present invention is directed to novel compounds, their use in therapy and pharmaceutical compositions comprising said novel compounds.
    Type: Application
    Filed: September 20, 2006
    Publication date: June 7, 2007
    Applicants: AstraZeneca AB, NPS PHARMACEUTICALS, INC.
    Inventors: Alexander Minidis, David Wensbo, Methvin Isaac, Abdelmalik Slassi, Jalaj Arora, Tao Xin, Louise Edwards, Caroline Eriksson, Veronica Profir, Per-Olov Bergstrom